Fundraising Fox

BiomX

NYSE: PHGE

Delaware corporation · 5 known investors

biomx.com

BiomX builds a portfolio of defense and security companies through subsidiaries, partnerships, and acquisitions, focusing on detection systems, aerial technologies, and infrastructure security. It targets field-proven products serving homeland security, critical infrastructure, border, transportation, and public safety needs within a Detection, Analysis, and Response operational chain.

AI & Machine LearningBiotechCybersecurityDeep TechDefense TechHardwarein /biomxbio@BiomX_Inc

Founders & leadership

JS
Jonathan SolomonChief Executive Officer
MB
Merav BassanChief Development Officer
MW
Marina WolfsonChief Financial Officer
JG
Jesse GoodmanNamed on SEC filing
AM
Alan MosesNamed on SEC filing
JL
Jonathan LeffNamed on SEC filing
GM
Gregory MerrilNamed on SEC filing
EW
Eddie WilliamsNamed on SEC filing
SB
Susan BlumNamed on SEC filing
RG
Russell GreigNamed on SEC filing
PS
Paul SekhriNamed on SEC filing
JG
Jonas GrossmanNamed on SEC filing

Investors · 5

Competitors · 3

by search overlap

Companies competing with BiomX for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements

$72.3M disclosed across 5 rounds · 2021–2026

$3.3MraisedJan 2026 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jesse GoodmanDirector
  • Alan MosesDirector
  • Jonathan LeffDirector
  • Jonathan SolomonExecutive Officer, Director
  • Merav BassanExecutive Officer
  • Gregory MerrilDirector
  • Eddie WilliamsDirector
  • Susan BlumDirector
  • Russell GreigDirector
  • Marina WolfsonExecutive Officer
Offering amount
$3.3M
Amount sold
$3.3M
Sales commissions
$210K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jan 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$61.5MraisedApr 2024 · 34 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jesse GoodmanDirector
  • Assaf OronExecutive Officer
  • Russell GreigDirector
  • Edward WilliamsDirector
  • Gregory MerrilDirector
  • Marina WolfsonExecutive Officer
  • Jonathan LeffDirector
  • Jonathan SolomonExecutive Officer, Director
  • Alan MosesDirector
  • Avi GabayExecutive Officer
  • Merav BassanExecutive Officer
Offering amount
$61.5M
Amount sold
$61.5M
Sales commissions
$1.4M
Placement agents
RBC Capital Markets, LLC, Laidlaw & Company (UK) Ltd.
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.5MraisedMar 2023 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Russell GreigDirector
  • Lynne SullivanDirector
  • Assaf OronExecutive Officer
  • Merav BassanExecutive Officer
  • Alan MosesDirector
  • Marina WolfsonExecutive Officer
  • Jonathan SolomonExecutive Officer, Director
Offering amount
$7.5M
Amount sold
$1.5M
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3MraisedJan 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonas GrossmanDirector
  • Lynne SullivanDirector
  • Gbola AmusaDirector
  • Marina WolfsonExecutive Officer
  • Russell GreigDirector
  • Alan MosesDirector
  • Paul SekhriDirector
  • Merav BassanExecutive Officer
  • Jonathan Eitan SolomonExecutive Officer, Director
Offering amount
$5M
Amount sold
$3M
Minimum investment
$3M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3MraisedOct 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan Eitan SolomonExecutive Officer, Director
  • Paul SekhriDirector
  • Russell GreigDirector
  • Jonas GrossmanDirector
  • Lynne SullivanDirector
  • Sailaja PuttaguntaExecutive Officer
  • Marina WolfsonExecutive Officer
  • Merav BassanExecutive Officer
  • Alan MosesDirector
  • Gbola AmusaDirector
Offering amount
$3M
Amount sold
$3M
Minimum investment
$3M
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.